RUNX1 upregulation via disruption of long-range transcriptional control by a novel t(5;21)(q13;q22) translocation in acute myeloid leukemia
暂无分享，去创建一个
Chi-kong Li | M. Ng | C. Cheng | N. P. Chan | T. S. Wan | N. Chan | Terry H. Y. Wong | Angela Z. Wang
[1] N. Komatsu,et al. Overexpression of RUNX1 short isoform has an important role in the development of myelodysplastic/myeloproliferative neoplasms. , 2017, Blood advances.
[2] R. Sood,et al. Role of RUNX1 in hematological malignancies. , 2017, Blood.
[3] Xiao Li,et al. Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes , 2017, Scientific Reports.
[4] G. Stein,et al. Transcriptional Auto-Regulation of RUNX1 P1 Promoter , 2016, PloS one.
[5] S. Orkin,et al. Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation , 2013, eLife.
[6] M. Poot,et al. Elucidation of a novel pathogenomic mechanism using genome-wide long mate-pair sequencing of a congenital t(16;21) in a series of three RUNX1-mutated FPD/AML pedigrees , 2012, Leukemia.
[7] S. Razin,et al. Transcriptional regulation and spatial organisation of the human AML1/RUNX1 gene , 2011, Journal of cellular biochemistry.
[8] Caroline L. Speck,et al. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. , 2007, Blood.
[9] Jean Mosser,et al. Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia , 2007, BMC Genomics.
[10] C. Férec,et al. RUNX1 translocations and fusion genes in malignant hemopathies. , 2011, Future oncology.